Thetis Pharmaceuticals, LLC

BRANFORD, CT 06405

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $206K
First Award Date 09/18/17
Most Recent Award Date 09/18/17

Key Personnel

Last Name Name Awards Contact
SCIAVOLINO FRANK SCIAVOLINO 1

1 Award Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 09/18/17 - 02/28/18

ABSTRACT Thetis plans to investigate TP-317, an innovative and potential first in-class therapeutic agent, as an oral therapy for the induction and maintenance of remission of intestinal inflammation symptoms in ulcerative colitis (UC) patients. While the precise etiology of UC is unknown, it is thought to result from an inappropriate inflammat...